| Title : Cost-utility analysis of memantine extended release added to cholinesterase inhibitors compared to cholinesterase inhibitor monotherapy for the treatment of moderate-to-severe dementia of the Alzheimer's type in the US - Saint-Laurent_2015_J.Med.Econ_18_930 |
| Author(s) : Saint-Laurent Thibault C , Ozer Stillman I , Chen S , Getsios D , Proskorovsky I , Hernandez L , Dixit S |
| Ref : J Med Econ , 18 :930 , 2015 |
| Abstract : |
| PubMedSearch : Saint-Laurent_2015_J.Med.Econ_18_930 |
| PubMedID: 26086535 |
| Title : Evaluating the cost effectiveness of donepezil in the treatment of Alzheimer's disease in Germany using discrete event simulation - Hartz_2012_BMC.Neurol_12_2 |
| Author(s) : Hartz S , Getsios D , Tao S , Blume S , Maclaine G |
| Ref : BMC Neurol , 12 :2 , 2012 |
| Abstract : |
| PubMedSearch : Hartz_2012_BMC.Neurol_12_2 |
| PubMedID: 22316501 |
| Title : NICE cost-effectiveness appraisal of cholinesterase inhibitors: was the right question posed? Were the best tools used? - Getsios_2007_Pharmacoeconomics_25_997 |
| Author(s) : Getsios D , Migliaccio-Walle K , Caro JJ |
| Ref : Pharmacoeconomics , 25 :997 , 2007 |
| Abstract : |
| PubMedSearch : Getsios_2007_Pharmacoeconomics_25_997 |
| PubMedID: 18047386 |
| Title : Assessing the health and economic impact of galantamine treatment in patients with Alzheimer's disease in the health care systems of different countries - Caro_2004_Drugs.Aging_21_677 |
| Author(s) : Caro J , Salas M , Ward A , Getsios D , Migliaccio-Walle K , Garfield F |
| Ref : Drugs & Aging , 21 :677 , 2004 |
| Abstract : |
| PubMedSearch : Caro_2004_Drugs.Aging_21_677 |
| PubMedID: 15287825 |
| Title : Rational choice of cholinesterase inhibitor for the treatment of Alzheimer's disease in Canada: a comparative economic analysis - Caro_2003_BMC.Geriatr_3_6 |
| Author(s) : Caro J , Getsios D , Migliaccio-Walle K , Ishak J , El-Hadi W |
| Ref : BMC Geriatr , 3 :6 , 2003 |
| Abstract : |
| PubMedSearch : Caro_2003_BMC.Geriatr_3_6 |
| PubMedID: 14675494 |
| Title : Assessment of health economics in Alzheimer's disease (AHEAD): treatment with galantamine in the UK - Ward_2003_Int.J.Geriatr.Psychiatry_18_740 |
| Author(s) : Ward A , Caro JJ , Getsios D , Ishak K , O'Brien J , Bullock R |
| Ref : Int J Geriatr Psychiatry , 18 :740 , 2003 |
| Abstract : |
| PubMedSearch : Ward_2003_Int.J.Geriatr.Psychiatry_18_740 |
| PubMedID: 12891643 |
| Title : Assessment of Health Economics in Alzheimer's Disease (AHEAD): Treatment with Galantamine in Sweden - Garfield_2002_Pharmacoeconomics_20_629 |
| Author(s) : Garfield FB , Getsios D , Caro JJ , Wimo A , Winblad B |
| Ref : Pharmacoeconomics , 20 :629 , 2002 |
| Abstract : |
| PubMedSearch : Garfield_2002_Pharmacoeconomics_20_629 |
| PubMedID: 12141890 |
| Title : Economic analysis of galantamine, a cholinesterase inhibitor, in the treatment of patients with mild to moderate Alzheimer's disease in the Netherlands - Caro_2002_Dement.Geriatr.Cogn.Disord_14_84 |
| Author(s) : Caro JJ , Salas M , Ward A , Getsios D , Mehnert A |
| Ref : Dementia & Geriatric Cognitive Disorders , 14 :84 , 2002 |
| Abstract : |
| PubMedSearch : Caro_2002_Dement.Geriatr.Cogn.Disord_14_84 |
| PubMedID: 12145455 |